Log In
Print
BCIQ
Print
Print this Print this
 

Minirinmelt, desmopressin (Minirin)

  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
DescriptionPeptide-based synthetic analogue of vasopressin
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationIncontinence
Indication DetailsTreat bedwetting; Treat primary nocturnal enuresis (PNE) in children
Regulatory Designation

Partner

Kyowa Hakko Kirin Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today